Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3754321
Max Phase: Preclinical
Molecular Formula: C23H31N5O
Molecular Weight: 393.54
Molecule Type: Small molecule
Associated Items:
ID: ALA3754321
Max Phase: Preclinical
Molecular Formula: C23H31N5O
Molecular Weight: 393.54
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=CCN1C(=O)CC[C@H]2[C@@H]3CC=C4C=C(c5nnn[nH]5)CC[C@]4(C)[C@H]3CC[C@@]21C
Standard InChI: InChI=1S/C23H31N5O/c1-4-13-28-20(29)8-7-19-17-6-5-16-14-15(21-24-26-27-25-21)9-11-22(16,2)18(17)10-12-23(19,28)3/h4-5,14,17-19H,1,6-13H2,2-3H3,(H,24,25,26,27)/t17-,18+,19+,22+,23+/m1/s1
Standard InChI Key: ORLWAHUCGZECGD-LEYYSGQMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 393.54 | Molecular Weight (Monoisotopic): 393.2529 | AlogP: 3.92 | #Rotatable Bonds: 3 |
Polar Surface Area: 74.77 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.30 | CX Basic pKa: | CX LogP: 3.07 | CX LogD: 1.47 |
Aromatic Rings: 1 | Heavy Atoms: 29 | QED Weighted: 0.79 | Np Likeness Score: 0.70 |
1. Aggarwal S, Mahapatra MK, Kumar R, Bhardwaj TR, Hartmann RW, Haupenthal J, Kumar M.. (2016) Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors., 24 (4): [PMID:26780831] [10.1016/j.bmc.2015.12.048] |
Source(1):